Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Lymphoid 3Sarcoma 1Myeloid 1Dermatologic 1Classical hematology 1CNS 1

Conditions

Gliosarcoma 3Glioblastoma 3Oligodendroglioma 2Glioma 2Central Nervous System Neoplasms 2Brain Neoplasms 2Astrocytoma 2Rhabdoid Tumor 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Juvenile 1Dendritic Cell Sarcoma, Interdigitating 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 56fludarabine phosphate 40Peripheral Blood Stem Cell Transplantation 32Cyclosporine 32Filgrastim 31Busulfan 31Mycophenolic Acid 30Antilymphocyte Serum 28Radiotherapy 27Whole-Body Irradiation 25Melphalan 23Tacrolimus 18Methylprednisolone 18Cord Blood Stem Cell Transplantation 17Methotrexate 16Etoposide 16Cytarabine 9Thiotepa 8sargramostim 6fludarabine 6aldesleukin 6Sirolimus 6Rituximab 6thymoglobulin 5Therapeutics 5Psychiatric Rehabilitation 5Granulocyte Colony-Stimulating Factor 5Doxorubicin 4Vincristine 3Prednisone 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Isotretinoin × Sarcoma × Clear all
NCT00217412 2014-06-17

Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or Leukemia

National Cancer Institute (NCI)

Phase 1 Completed
60 enrolled
CNSLymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Medulloblastoma, Neuroblastoma, Recurrence, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡